- All Courts
- Federal Courts
- Bankruptcies
- PTAB
- ITC
Filters
Like full text docket searches?
Get docket alerts, perform legal research, get updates of major decisions and orders, use our advanced analytics, and more. Request a Demo or create your account.
Date Filed
Dollars
Find cases based on dollar amount with searches like:
$100k-$10M.
Read the details here.
Displaying 474-488 of
1,261 results
1021 Exhibit: 1021 Byetta prescribing information Oct 2009
Document
IPR2024-00631, No. 1021 Exhibit - 1021 Byetta prescribing information Oct 2009 (P.T.A.B. Mar. 1, 2024)
|
|
Cite Document
1035 Exhibit: 1035 Lund, Emerging GLP1 Receptor Agonists, 16 EXPERT OP ON...
Document
IPR2024-00631, No. 1035 Exhibit - 1035 Lund, Emerging GLP1 Receptor Agonists, 16 EXPERT OP ON EMERGING DRUG (P.T.A.B. Mar. 1, 2024)
|
|
Cite Document
1047 Exhibit: 1047 Tamimi, Drug Development From Concept to Marketing, 113 NE...
Document
IPR2024-00631, No. 1047 Exhibit - 1047 Tamimi, Drug Development From Concept to Marketing, 113 NEPHRON CLIN (P.T.A.B. Mar. 1, 2024)
|
|
Cite Document
1042 Exhibit: 1042 WO 9111457
Document
IPR2024-00631, No. 1042 Exhibit - 1042 WO 9111457 (P.T.A.B. Mar. 1, 2024)
|
|
Cite Document
1029 Exhibit: 1029 Jimenez Solem, Dulaglutide, a Long Acting GLP1 Analog Fuse...
Document
IPR2024-00631, No. 1029 Exhibit - 1029 Jimenez Solem, Dulaglutide, a Long Acting GLP1 Analog Fused with an F (P.T.A.B. Mar. 1, 2024)
|
|
Cite Document
1044 Exhibit: 1044 Rohatagi, Model Based Development of a PPARγ Agonist, Rivog...
Document
IPR2024-00631, No. 1044 Exhibit - 1044 Rohatagi, Model Based Development of a PPARγ Agonist, Rivoglitazone, t (P.T.A.B. Mar. 1, 2024)
|
|
Cite Document
1076 Exhibit: 1076 ClinicalTrialsgov Background, CLINICALTRIALSGOV, httpsclin...
Document
IPR2024-00631, No. 1076 Exhibit - 1076 ClinicalTrialsgov Background, CLINICALTRIALSGOV, httpsclinicaltri (P.T.A.B. Mar. 1, 2024)
|
|
Cite Document
1041 Exhibit: 1041 WO 03002136
Document
IPR2024-00631, No. 1041 Exhibit - 1041 WO 03002136 (P.T.A.B. Mar. 1, 2024)
|
|
Cite Document
1501 Exhibit: 1501 Declaration of Judith Korner, MD, PhD
Document
IPR2024-00631, No. 1501 Exhibit - 1501 Declaration of Judith Korner, MD, PhD (P.T.A.B. Mar. 1, 2024)
|
|
Cite Document
1082 Exhibit: 1082 Scheduling Order, Novo Nordisk Inc v Rio Biopharmaceuticals I...
Document
IPR2024-00631, No. 1082 Exhibit - 1082 Scheduling Order, Novo Nordisk Inc v Rio Biopharmaceuticals Inc, No (P.T.A.B. Mar. 1, 2024)
|
|
Cite Document
1087 Exhibit: 1087 Prosecution history excerpts for US Patent No 9,764,003
Document
IPR2024-00631, No. 1087 Exhibit - 1087 Prosecution history excerpts for US Patent No 9,764,003 (P.T.A.B. Mar. 1, 2024)
|
|
Cite Document
1012 Exhibit: 1012 Lovshin, Incretin Based Therapies for Type 2 Diabetes Mellitus,...
Document
IPR2024-00631, No. 1012 Exhibit - 1012 Lovshin, Incretin Based Therapies for Type 2 Diabetes Mellitus, 5 NATU (P.T.A.B. Mar. 1, 2024)
|
|
Cite Document
1506 Exhibit: 1506 CV of Hugh DC Smyth, PhD
Document
IPR2024-00631, No. 1506 Exhibit - 1506 CV of Hugh DC Smyth, PhD (P.T.A.B. Mar. 1, 2024)
|
|
Cite Document
1058 Exhibit: 1058 Blonde, Comparison of Liraglutide Versus Other Incretin Relate...
Document
IPR2024-00631, No. 1058 Exhibit - 1058 Blonde, Comparison of Liraglutide Versus Other Incretin Related Anti H (P.T.A.B. Mar. 1, 2024)
|
|
Cite Document
1028 Exhibit: 1028 Holst, Glucagon Like Peptide 1 and Inhibitors of Dipeptidyl Pept...
Document
IPR2024-00631, No. 1028 Exhibit - 1028 Holst, Glucagon Like Peptide 1 and Inhibitors of Dipeptidyl Peptidase (P.T.A.B. Mar. 1, 2024)
|
|
Cite Document
